Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis
Sign Up to like & getrecommendations! Published in 2024 at "Blood Cancer Journal"
DOI: 10.1038/s41408-024-01056-0
Abstract: the doses of both agents were rather high. read more here.
Keywords: ruxolitinib patients; emapalumab ruxolitinib; combined emapalumab; haemophagocytic lymphohistiocytosis ... See more keywords